{
  "paper_metadata": {
    "pmid": "34646395",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1310_1313delAAGA",
      "protein_notation": "p.Lys437Ilefs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2,
        "demographics": "early onset women diagnosed with TNBC at ages 35 and 38",
        "phenotype": "triple negative breast cancer and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 35,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with TNBC",
          "evidence_sentence": "The BRCA2 c.1310_1313delAAGA variant, a specific founder variant from the North-East of Morocco, was detected in early onset women diagnosed with both TNBC (at the age of 35) and OC (at the age of 38)."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 38,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with ovarian cancer",
          "evidence_sentence": "The BRCA2 c.1310_1313delAAGA variant, a specific founder variant from the North-East of Morocco, was detected in early onset women diagnosed with both TNBC (at the age of 35) and OC (at the age of 38)."
        }
      ],
      "functional_data": {
        "summary": "The variant causes a frame-shift which changes a Lysine to an Isoleucine at codon 437 and creates a premature stop codon at position 22 of the new reading frame.",
        "assays": []
      },
      "segregation_data": "The variant is found in affected individuals.",
      "population_frequency": null,
      "evidence_level": "strong evidence for pathogenicity based on clinical presentation and family history.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is a founder mutation in the North-East of Morocco.",
      "key_quotes": [
        "The BRCA2 c.1310_1313delAAGA variant, a specific founder variant from the North-East of Morocco, was detected in early onset women diagnosed with both TNBC (at the age of 35) and OC (at the age of 38)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1658T>G",
      "protein_notation": "p.Leu553Ter",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "one patient without family history, diagnosed at age 36",
        "phenotype": "triple negative breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": 36,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with TNBC",
          "evidence_sentence": "The BRCA2 c.1658T>G (p.Leu553Ter) variant, located in exon 11, causes a non-sense substitution. It was observed in one patient without family history, diagnosed with TNBC at the age of 36."
        }
      ],
      "functional_data": {
        "summary": "The variant causes a non-sense substitution leading to a truncated protein.",
        "assays": []
      },
      "segregation_data": "The variant is found in an affected individual.",
      "population_frequency": null,
      "evidence_level": "strong evidence for pathogenicity based on clinical presentation.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was associated with breast-ovarian cancer and hereditary cancer-predisposing syndrome.",
      "key_quotes": [
        "The BRCA2 c.1658T>G (p.Leu553Ter) variant, located in exon 11, causes a non-sense substitution. It was observed in one patient without family history, diagnosed with TNBC at the age of 36."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were successfully extracted."
  }
}